Predictors of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers
Kelly Metcalfe(University of Toronto), Steven A. Narod(Women's College Hospital)
Cited by 233
Related Papers
Breast Cancer Mortality After a Diagnosis of Ductal Carcinoma In Situ
|JAMA Oncology|2015|618
Effect of Short-Term Hormone Replacement Therapy on Breast Cancer Risk Reduction After Bilateral Prophylactic Oophorectomy in <i>BRCA1</i> and <i>BRCA2</i> Mutation Carriers: The PROSE Study Group
|Journal of Clinical Oncology|2005|406
Germline <i>BRCA</i> Mutations in a Large Clinic-Based Cohort of Patients With Pancreatic Adenocarcinoma
|Journal of Clinical Oncology|2015|396
Clinical and pathologic findings of prophylactic salpingo-oophorectomies in 159 BRCA1 and BRCA2 carriers
|Gynecologic Oncology|2005|377
Occult Carcinoma in Prophylactic Oophorectomy Specimens
|The American Journal of Surgical Pathology|2001|335